Therapeutic Advances in Ophthalmology: review time and acceptance speed
ISSN 2515-8414 · SAGE Publishing · Medicine
Half of the articles Therapeutic Advances in Ophthalmology accepted in 2021 were accepted within 141 days of submission (n = 78); the middle half took 94–206 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Therapeutic Advances in Ophthalmology take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2021 | 78 | 94 | 141 | 206 | — | 2.6% | 0% |
| 2020 | 54 | 102 | 146 | 217 | — | 1.8% | 0% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Distribution in 2021
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 10 | 12.8% |
| 30–59 | 3 | 3.8% |
| 60–89 | 6 | 7.7% |
| 90–119 | 15 | 19.2% |
| 120–149 | 7 | 9.0% |
| 150–179 | 11 | 14.1% |
| 180–209 | 8 | 10.3% |
| 210–239 | 8 | 10.3% |
| 240–269 | 2 | 2.6% |
| 270–299 | 3 | 3.8% |
| 300–329 | 1 | 1.3% |
| 330–359 | 2 | 2.6% |
| 360+ | 2 | 2.6% |
From acceptance to online publication
After acceptance, half of the 2021 articles appeared online within 39 days (middle half 29–52 days, n = 79).
From submission to online publication, the median was 184 days (middle half 123–252 days, n = 78).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Open access (listed in DOAJ). Listed APC: $2,650 (DOAJ).
No institutional payments for this journal are recorded in OpenAPC.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | Yes (DOAJ record) |
|---|---|
| Articles indexed for MEDLINE in 2021 | None found (the journal may be in PubMed through PubMed Central instead) |
| Retractions | 0 retracted articles among 219 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 2.6% of 2021 articles |
| Publication volume | 70 articles added to PubMed in 2021 (+37% vs 2020). |
Topics and scope
- Retinal Diseases and Treatments (14% of indexed topics)
- Glaucoma and retinal disorders (10% of indexed topics)
- Retinal and Macular Surgery (8% of indexed topics)
- Corneal surgery and disorders (8% of indexed topics)
- Ophthalmology and Visual Impairment Studies (7% of indexed topics)
- Ocular Diseases and Behçet’s Syndrome (6% of indexed topics)
Medicine journalsOphthalmology journalsRadiology, Nuclear Medicine and Imaging journals
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2021 figures are compared with the 2021 median of Therapeutic Advances in Ophthalmology, 141 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Taiwan Journal of Ophthalmology | 63 (2021, n = 56) | No fee (DOAJ) | — | Yes | No |
| Ophthalmology and Therapy | 36 (2021, n = 111) | $7,675 | — | Yes | No |
| Japanese Journal of Ophthalmology | 161 (2021, n = 80) | ≈$3,790 | — | No | Yes |
| International Ophthalmology | 166 (2021, n = 497) | ≈$3,790 | — | No | Yes |
| International Journal of Ophthalmology | 138 (2021, n = 311) | $1,800 | — | Yes | No |
| Beyoglu Eye Journal | 103 (2021, n = 61) | No fee (DOAJ) | — | Yes | No |
| Journal of Ophthalmic and Vision Research | 253 (2021, n = 79) | $300 | — | Yes | No |
| Graefe s Archive for Clinical and Experimental Ophthalmology | 121 (2021, n = 415) | ≈$2,990 | — | No | Yes |
| Acta Ophthalmologica | 167 (2021, n = 273) | ≈$4,990 | — | No | Yes |
No journals match these filters.
Frequently asked questions
How long does Therapeutic Advances in Ophthalmology take to accept a paper?
Half of the articles Therapeutic Advances in Ophthalmology accepted in 2021 were accepted within 141 days of submission (n = 78); the middle half took 94–206 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Therapeutic Advances in Ophthalmology articles published online?
Half of the articles accepted in 2021 appeared online within 39 days of acceptance (n = 79).
Does Therapeutic Advances in Ophthalmology charge an article processing charge (APC)?
Listed APC: $2,650 (DOAJ).
Sources and method
Journal identity: ISSN-L 2515-8414; NLM ID 101728805; OpenAlex record. Speed figures use 78 articles accepted in 2021 with valid dates; excluded records for that year: accepted before received 1.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.